SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Ahead of the ICRS Summit in Porto, SmartTRAK interviews Past President Dr. Daniel Grande on key joint re...
Senior analyst Elizabeth Anderson interviews Merakris Therapeutics CEO Chris Broderick about MTX-001, an...
ProDevLabs provides an indepth look at the CAMPS reset in wound care and the convergence with regenerati...
At OARSI 2026, Serene's CEO discussed Tin-117m microparticles, a radiotherapeutic targeting joint inflam...
Incoming OARSI President Nancy Lane, MD, discusses the evolving landscape of osteoarthritis treatment, t...
SmartTRAK interviewed Alafair’s leadership to discuss how their proprietary alginate technology is disru...
Pacira BioSciences’ CEO Frank Lee discusses advances in orthopedic pain management, real-world evidence ...
Ranfac CEO Harlan Adler discusses the company's strategic pivot from contract manufacturing to owning cl...
The 2026 cartilage replacement market is moving away from "one-size-fits-all" solutions toward a diversi...
Throughout 2025, SmartTRAK empowered MedTech professionals to Be The Expert by providing timely, data-dr...
Login